Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mak, Po Yee
389  Ergebnisse:
Personensuche X
?
1

Correction: Mitochondrial regulation of GPX4 inhibition–med..:

Akiyama, Hiroki ; Zhao, Ran ; Ostermann, Lauren B....
Leukemia.  38 (2024)  4 - p. 926-926 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Epichaperome inhibition targets TP53-mutant AML and AML ste..:

Carter, Bing Z. ; Mak, Po Yee ; Muftuoglu, Muharrem...
Blood.  142 (2023)  12 - p. 1056-1070 , 2023
Link: https://doi.org/10.1182/..
 
?
3

Inhibition of menin, BCL-2, and FLT3 combined with a hypome..:

Carter, Bing Z. ; Mak, Po Yee ; Tao, Wenjing...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
4

Mitochondrial regulation of GPX4 inhibition–mediated ferrop..:

Akiyama, Hiroki ; Zhao, Ran ; Ostermann, Lauren B....
Leukemia.  38 (2023)  4 - p. 729-740 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Combined inhibition of BCL-2 and MCL-1 overcomes BAX defici..:

Carter, Bing Z. ; Mak, Po Yee ; Tao, Wenjing...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
6

Correction: Combined inhibition of BCL-2 and MCL-1 overcome..:

Carter, Bing Z. ; Mak, Po Yee ; Tao, Wenjing...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

Poster: AML-147 C-MYC Targeting by Degradation: Novel Dual ..:

Nishida, Yuki ; Scruggs, Darah A ; Ayoub, Edward...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S127 , 2022
Link: https://doi.org/10.1016/..
 
?
8

AML-147 C-MYC Targeting by Degradation: Novel Dual c-Myc/GS..:

Nishida, Yuki ; Scruggs, Darah A ; Ayoub, Edward...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S218 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Inhibition of BCL2A1 by STAT5 inactivation overcomes resist..:

Yamatani, Kotoko ; Ai, Tomohiko ; Saito, Kaori...
Translational Oncology.  18 (2022)  - p. 101354 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Poster: AML-027: Menin Inhibition Decreases Bcl-2 and Bcl-x..:

Carter, Bing ; Tao, Wenjing ; Mak, Po Yee...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S209 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Final results of a phase 2 clinical trial of LCL161, an ora..:

Pemmaraju, Naveen ; Carter, Bing Z. ; Bose, Prithviraj...
Blood Advances.  5 (2021)  16 - p. 3163-3173 , 2021
Link: https://doi.org/10.1182/..
 
?
12

AML-027: Menin Inhibition Decreases Bcl-2 and Bcl-xL and En..:

Carter, Bing ; Tao, Wenjing ; Mak, Po Yee...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S277-S278 , 2021
Link: https://doi.org/10.1016/..
 
?
13

AXL/MERTK inhibitor ONO-7475 potently synergizes with venet..:

Post, Sean M. ; Ma, Huaxian ; Malaney, Prerna...
Haematologica.  107 (2021)  6 - p. 1311-1322 , 2021
Link: https://doi.org/10.3324/..
 
?
14

AML-356: High Dimensional Analytic Approaches Identify Stre..:

Muftuoglu, Muharrem ; Mak, Po Yee ; Ruvolo, Vivian...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S207 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Targeting MCL-1 dysregulates cell metabolism and leukemia-s..:

Carter, Bing Z. ; Mak, Po Yee ; Tao, Wenjing...
Haematologica.  107 (2020)  1 - p. 58-76 , 2020
Link: https://doi.org/10.3324/..
 
1-15